The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023, in
The prognosis and maintenance of response after treatment discontinuation following remission lack proper characterization. Real-world data obtained from national registries
Dr. Gudjonsson highlights disease memory and how it can provide a potential treatment target.
Dr. Blauvelt discusses results from his research study where high doses of a medication is provided to “knock out” disease
Dr. Smith reviews how biomarkers can be used to identify patients at risk for severe disease and those who would
Recently, a study was conducted on the effect of apremilast on vascular inflammation and cardiometabolic functions with an impressively comprehensive
The United States Food and Drug Administration (FDA) has approved deucravacitinib to treat psoriasis. Recently, 52-week efficacy and safety data
Real-world evidence studies become crucial to achieving the evidence needed in clinical practice. But how are data evaluated in the
Focus on Psoriasis – A Report from the 2021 Virtual EADV Congress Download PDF
Sleep disorders are frequently found in patients with psoriasis, but the specific factors have remained elusive and have never been
